The online version of this article (doi:10.1186/1475-2840-11-31) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
ST, TS and LPP conceptualized, designed the studies and wrote this paper. ST performed the skin vasoconstrictor assays. SJ led the clinical work and SN performed the biochemical analyses. All authors read and approved the final manuscript.
The metabolic syndrome is associated with increased risk for both diabetes and coronary artery disease, which insulin resistance alone does not satisfactorily explain. We propose an additional and complementary underlying mechanism of glucocorticoid resistance.
Using acanthosis nigricans (AN) and skin vasoconstrictor (SVC) response to topically applied beclomethasone dipropionate as markers of insulin and glucocorticoid resistance, respectively, we compared anthropometric, biochemical, pro-inflammatory markers and the SVC response in subjects with AN in two studies: STUDY 1 was used to compare subjects with AN (Grade 4, n = 32), with those without AN (n = 68) while STUDY 2 compared these responses among a cross-section of diabetic patients (n = 109) with varying grades of AN (grade 0, n = 30; grade 1, n = 24; grade 2, n = 18; grade 3, n = 25; grade 4, n = 12).
In both studies there was an inverse relationship between AN Grade 4 and the SVC response, (P < 0.001). In STUDY 1, AN Grade 4 was associated with age, waist circumference, BMI, fasting blood glucose, plasma lipids and hs-CRP (P < 0.05). SVC was an independent predictor of CRP and those with combined AN and a negative SVC response, CRP levels were highest. In Study 2 when the SVC response in subjects with type 2 diabetes mellitus with varying degrees of AN was studied, it showed that for any degree of AN, the SVC response is more likely to be negative and was independent of gender and ethnicity.
An absent SVC response represents a new biomarker for the metabolic syndrome and the exaggerated inflammatory response, which characterizes the metabolic syndrome, may be an outcome of deficient glucocorticoid action in vascular tissue.
Authors’ original file for figure 112933_2011_463_MOESM1_ESM.pdf
Authors’ original file for figure 212933_2011_463_MOESM2_ESM.png
Authors’ original file for figure 312933_2011_463_MOESM3_ESM.jpeg
Authors’ original file for figure 412933_2011_463_MOESM4_ESM.jpeg
Authors’ original file for figure 512933_2011_463_MOESM5_ESM.jpeg
Authors’ original file for figure 612933_2011_463_MOESM6_ESM.jpeg
Enzi G, Busetto L, Inelman EM, Coin A, Sergi G: Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni's "De Sedibus et causis morborum per anatomen indagata". J Obes. 2003, 27: 534-535. 10.1038/sj.ijo.0802268. CrossRef
Walker BR: Cortisol- cause and cure for metabolic syndrome?. Diabet Med. 2008, 23: 1281-1288. CrossRef
Pinheiro AC, Rojas P, Carrasco F, Gomez P, Mayas N, Morales I: Acanthosis nigricans as an indicator of insulin resistance in Chilean adult population. Nutr Hosp. 2011, 26 (5): 940-944. PubMed
McKenzie AW, Stoughton RB: Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1962, 86: 608-610. 10.1001/archderm.1962.01590110044005. CrossRef
Barry BW, Woodford R: Activity and bioavailability of topical steroids: In vivo/in vitro correlations for the vasoconstrictor test. J Clin Pharmac. 1978, 3: 43-65.
Teelucksingh S: Glucocorticoids and the skin. PhD thesis. 1995, University of Edinburgh, Scotland
Panarelli M, Holloway CD, Fraser R, Connell JMC, Ingram MC, et al: Glucorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab. 1998, 83: 1846-1852. 10.1210/jc.83.6.1846. PubMed
Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Legrand CB, et al: 11beta-hydroxsteroid dehydrogenase 1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med. 2005, 202 (4): 517-527. 10.1084/jem.20050119. PubMedCentralCrossRefPubMed
- Does insulin resistance co-exist with glucocorticoid resistance in the metabolic syndrome? Studies comparing skin sensitivity to glucocorticoids in individuals with and without acanthosis nigricans
Lexley Pinto Pereira
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II